Literature DB >> 6538053

Female urethral syndrome: clinical and urodynamic perspectives.

G A Barbalias, E M Meares.   

Abstract

Eighteen women with the urethral syndrome were studied urodynamically with synchronous video-pressure flow studies and electromyography of the external urethral sphincter (EUS). When compared with an age and sex matched control group, the most striking finding was a significantly higher than normal maximum urethral closure pressure. Abnormal and low urinary flow rates, instability of the intraurethral pressure at rest, incomplete funnelling of the bladder neck, and distal urethral narrowing during voiding constitute other typical urodynamic findings in the female urethral syndrome. Detrusor-striated sphincter dyssynergia or primary striated sphincter spasm was not observed. Even though striated EUS spasticity cannot be excluded as a cause of this syndrome in some patients, an autonomically mediated spasm of the smooth muscle sphincter seems plausible to explain both our urodynamic findings and a favorable response of 4 patients treated with alpha-blocking agents.

Entities:  

Mesh:

Year:  1984        PMID: 6538053     DOI: 10.1016/0090-4295(84)90024-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  An effective treatment for functional urinary incoordination.

Authors:  H C Philips; H N Fenster; D Samsom
Journal:  J Behav Med       Date:  1992-02

2.  Urethral syndrome: response to alpha-adrenergic blocking agents.

Authors:  Deepali Sinha; A Arunkalaivanan
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-11-01

3.  Aetiology of urinary symptoms in sexually active women.

Authors:  R G Feldman; A L Johnson; P C Schober; C J Bignell; G L Ridgway; J D Oriel
Journal:  Genitourin Med       Date:  1986-10

Review 4.  [Urethral pain syndrome: fact or fiction--an update].

Authors:  N M Dreger; S Degener; S Roth; A S Brandt; D A Lazica
Journal:  Urologe A       Date:  2015-09       Impact factor: 0.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.